alanine has been researched along with Obesity in 150 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Excerpt | Relevance | Reference |
---|---|---|
"Integrase inhibitors, including dolutegravir (DTG), are associated with weight gain and obesity, especially when combined with tenofovir alafenamide (TAF)." | 9.12 | The predicted risk of adverse pregnancy outcomes as a result of treatment-associated obesity in a hypothetical population receiving tenofovir alafenamide/emtricitabine/dolutegravir, tenofovir disoproxil fumarate/emtricitabine/dolutegravir or tenofovir dis ( Asif, S; Baxevanidi, E; Chandiwana, N; Fairlie, L; Hill, A; Masenya, M; Serenata, C; Sokhela, S; Venter, WDF, 2021) |
"Obesity is associated with altered glycine metabolism in humans." | 7.96 | Obesity increases hepatic glycine dehydrogenase and aminomethyltransferase expression while dietary glycine supplementation reduces white adipose tissue in Zucker diabetic fatty rats. ( Edwards, AK; McKnight, SM; Satterfield, MC; Simmons, RM; Wu, G, 2020) |
"L-alanine (Ala) and L-arginine (Arg) have been reported to regulate pancreatic β-cell physiology and to prevent body fat accumulation in diet-induced obesity." | 7.85 | Benefits of L-alanine or L-arginine supplementation against adiposity and glucose intolerance in monosodium glutamate-induced obesity. ( Araujo, TR; Balbo, SL; Batista, TM; Bonfleur, ML; Boschero, AC; Carneiro, EM; Freitas, IN; Ribeiro, RA; Santos-Silva, JC; Vettorazzi, JF, 2017) |
"This study was undertaken to investigate the impact of the Pro12Ala (rs1801282) polymorphism of the peroxisome proliferator-activated receptor gamma-2 (PPARgamma-2) gene on obesity or body mass index (BMI) and plasma leptin, insulin, adiponectin and lipid levels in a sample of the Tunisian population." | 7.75 | Gender-specific effect of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma-2 gene on obesity risk and leptin levels in a Tunisian population. ( Ben Ali, S; Ben Yahia, F; Elasmi, M; Feki, M; Ftouhi, B; Haj-Taieb, S; Jemaa, R; Kaabachi, N; Kallel, A; Sanhagi, H; Sediri, Y; Slimane, H; Souheil, O, 2009) |
"Obesity is an important correlate of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels." | 7.74 | Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study. ( D'Agostino, RB; Ellison, RC; Fox, CS; Hwang, SJ; Liang, TJ; Loomba, R; O'Donnell, CJ; Vasan, RS, 2008) |
" We examined the association between Pro12Ala polymorphism of PPARG2, type 2 diabetes mellitus (DM2), and peripheral insulin sensitivity in a population with a high intake of oleic acid." | 7.73 | Pro12Ala polymorphism of the PPARG2 gene is associated with type 2 diabetes mellitus and peripheral insulin sensitivity in a population with a high intake of oleic acid. ( Cardona, F; de la Cruz Almaráz, M; Esteva, I; Morcillo, S; Olveira, G; Rojo-Martínez, G; Ruiz de Adana, Mde L; Soriguer, F; Tinahones, F, 2006) |
"The relationship between changes in ketone concentrations and leucine metabolism (seven obese subjects), glucose and alanine metabolism (seven obese subjects) was investigated using radioisotopic techniques after 12 h, 60 h and 2 weeks starvation." | 7.69 | The effect of starvation on leucine, alanine and glucose metabolism in obese subjects. ( Boroujerdi, MA; Scobie, IN; Sönksen, PH; Umpleby, AM, 1995) |
"The "in vivo" handling of L-alanine in 24 hours starved rats, in which obesity was induced by feeding with cafeteria diet, was compared with that of starved control rats." | 7.68 | In vivo C14-L-alanine metabolism in rat dietary obesity induced by cafeteria diet. ( Gianotti, M; Palou, A; Pons, A; Roca, P, 1990) |
"Obesity was associated with the level of serum liver enzymes." | 5.72 | The association between obesity with serum levels of liver enzymes, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and gamma-glutamyl transferase in adult women. ( Ajami, M; Alizadeh, A; Doaei, S; Esmaeili, M; Gholamalizadeh, M; Hajipour, A; Hasanpour Ardekanizadeh, N; Houshiarrad, A; Jalili, V; Mokhtari, Z; Poorahmadi, Z; Shafaei, H; Shafie, F, 2022) |
"Glycogen levels were also lower in this region." | 5.36 | Obesity and type 2 diabetes in rats are associated with altered brain glycogen and amino-acid homeostasis. ( Benie, AJ; Bouman, SD; Schousboe, A; Sickmann, HM; Waagepetersen, HS, 2010) |
"Integrase inhibitors, including dolutegravir (DTG), are associated with weight gain and obesity, especially when combined with tenofovir alafenamide (TAF)." | 5.12 | The predicted risk of adverse pregnancy outcomes as a result of treatment-associated obesity in a hypothetical population receiving tenofovir alafenamide/emtricitabine/dolutegravir, tenofovir disoproxil fumarate/emtricitabine/dolutegravir or tenofovir dis ( Asif, S; Baxevanidi, E; Chandiwana, N; Fairlie, L; Hill, A; Masenya, M; Serenata, C; Sokhela, S; Venter, WDF, 2021) |
"We tested the effect-modifying role of Pro12Ala on the 1 year change in obesity-related traits in a randomised clinical trial of treatment with metformin (n = 989), troglitazone (n = 363) or lifestyle modification (n = 1,004) vs placebo (n = 1,000) for diabetes prevention in high-risk individuals." | 5.12 | The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. ( Altshuler, D; Delahanty, L; Florez, JC; Franks, PW; Hanson, RL; Jablonski, KA; Kahn, SE; Knowler, WC, 2007) |
"The associations for the following amino acids with HOMA-IR at the 3-year follow-up significantly varied by obesity status: isoleucine, valine, tyrosine, alanine, and methionine (all p for interaction <0." | 4.12 | Associations of serum amino acids with insulin resistance among people with and without overweight or obesity: A prospective study in Japan. ( Chen, S; Eguchi, M; Fukunaga, A; Kabe, I; Kochi, T; Miki, T; Mizoue, T; Nanri, A, 2022) |
"Obesity is associated with altered glycine metabolism in humans." | 3.96 | Obesity increases hepatic glycine dehydrogenase and aminomethyltransferase expression while dietary glycine supplementation reduces white adipose tissue in Zucker diabetic fatty rats. ( Edwards, AK; McKnight, SM; Satterfield, MC; Simmons, RM; Wu, G, 2020) |
"L-alanine (Ala) and L-arginine (Arg) have been reported to regulate pancreatic β-cell physiology and to prevent body fat accumulation in diet-induced obesity." | 3.85 | Benefits of L-alanine or L-arginine supplementation against adiposity and glucose intolerance in monosodium glutamate-induced obesity. ( Araujo, TR; Balbo, SL; Batista, TM; Bonfleur, ML; Boschero, AC; Carneiro, EM; Freitas, IN; Ribeiro, RA; Santos-Silva, JC; Vettorazzi, JF, 2017) |
"This study was undertaken to investigate the impact of the Pro12Ala (rs1801282) polymorphism of the peroxisome proliferator-activated receptor gamma-2 (PPARgamma-2) gene on obesity or body mass index (BMI) and plasma leptin, insulin, adiponectin and lipid levels in a sample of the Tunisian population." | 3.75 | Gender-specific effect of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma-2 gene on obesity risk and leptin levels in a Tunisian population. ( Ben Ali, S; Ben Yahia, F; Elasmi, M; Feki, M; Ftouhi, B; Haj-Taieb, S; Jemaa, R; Kaabachi, N; Kallel, A; Sanhagi, H; Sediri, Y; Slimane, H; Souheil, O, 2009) |
"Obesity is an important correlate of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels." | 3.74 | Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study. ( D'Agostino, RB; Ellison, RC; Fox, CS; Hwang, SJ; Liang, TJ; Loomba, R; O'Donnell, CJ; Vasan, RS, 2008) |
" We examined the association between Pro12Ala polymorphism of PPARG2, type 2 diabetes mellitus (DM2), and peripheral insulin sensitivity in a population with a high intake of oleic acid." | 3.73 | Pro12Ala polymorphism of the PPARG2 gene is associated with type 2 diabetes mellitus and peripheral insulin sensitivity in a population with a high intake of oleic acid. ( Cardona, F; de la Cruz Almaráz, M; Esteva, I; Morcillo, S; Olveira, G; Rojo-Martínez, G; Ruiz de Adana, Mde L; Soriguer, F; Tinahones, F, 2006) |
"To determine whether there are variations in leptin levels according to the beta(3)-adrenoceptor (beta(3)-AR) Trp64Arg and uncoupling protein 1 (UCP1) -3826A-->G polymorphisms, given the regulatory role of catecholamines through the beta(3)-AR in leptin production and the previously reported association of the UCP1 -3826A-->G variant with obesity." | 3.72 | The Arg64 allele of the beta 3-adrenoceptor gene but not the -3826G allele of the uncoupling protein 1 gene is associated with increased leptin levels in the Spanish population. ( Fernández-Pérez, C; González-Sánchez, JL; Martínez-Larrad, MT; Palou, A; Proenza, AM; Ramis, JM; Serrano-Ríos, M, 2004) |
" The objective of the current study was to examine the potential impact of a C-->T substitution in exon 4, resulting in an alanine to valine substitution at codon 55, on the Metabolic Syndrome in 284 unrelated Swedish men born in 1944." | 3.71 | Lack of association between the uncoupling protein-2 Ala55Val gene polymorphism and phenotypic features of the Metabolic Syndrome. ( Björntorp, P; Bouchard, C; Rosmond, R, 2002) |
"The relationship between changes in ketone concentrations and leucine metabolism (seven obese subjects), glucose and alanine metabolism (seven obese subjects) was investigated using radioisotopic techniques after 12 h, 60 h and 2 weeks starvation." | 3.69 | The effect of starvation on leucine, alanine and glucose metabolism in obese subjects. ( Boroujerdi, MA; Scobie, IN; Sönksen, PH; Umpleby, AM, 1995) |
"Membrane vesicles from the small intestine brush border were obtained and used to determine the possible effects of genetic or nutritional obesity on L-alanine uptake." | 3.69 | L-alanine transport in small intestine brush-border membrane vesicles of obese rats. ( Alemany, M; Remesar, X; Sanchís, D, 1994) |
"The "in vivo" handling of L-alanine in 24 hours starved rats, in which obesity was induced by feeding with cafeteria diet, was compared with that of starved control rats." | 3.68 | In vivo C14-L-alanine metabolism in rat dietary obesity induced by cafeteria diet. ( Gianotti, M; Palou, A; Pons, A; Roca, P, 1990) |
"To investigate glucagon (IRG) and insulin (IRI) responses to alanine infusion in obesity and to assess the effect of body weight reduction with respect to hormonal balance, we compared six obese subjects with nine normal weight controls." | 3.67 | Plasma glucagon response to intravenous alanine in obese and non-obese subjects. ( Asano, T; Kan, K; Ninomiya, H; Okumura, M; Yamamoto, T, 1989) |
"The methods utilized in our laboratory for a biochemical approach of obesity include dietary manipulations, fatty acid analysis of tissue lipids, in vivo lipogenesis from [3H H2O and [1-14C] acetate, in vitro utilization of [3H] H2O, [U-14C] glucose, [U-14C] fructose, [U-14C] alanine and [1-14C] acetate by adipose tissue fragments, hormone sensitivity (to insulin and catecholamines), and the activity of enzymes such as fatty acid synthetase and adenylate cyclase in adipose tissue extracts." | 3.66 | Experimental basis of obesity. ( Christophe, J; Dehaye, JP; Winand, J, 1978) |
"Plasma concentrations of glucagon, insulin, glucose, and individual plasma amino acids were measured in normal nonobese and obese subjects before and after 3 days of dexamethasone treatment (2 mg/day) and in patients with Cushing's syndrome." | 3.65 | Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man. ( Felig, P; Hendler, R; Wise, JK, 1973) |
"Obesity was negatively associated to clinical improvement after Remdesivir (OR 0." | 1.72 | The impact of obesity and dyslipidemia on Remdesivir effectiveness in hospitalized patients with SARS-CoV-2-related pneumonia: An observational study. ( Biondi, G; Brugaletta, G; Oliveri, R; Romano, M; Romano, R; San Lio, PM; Scicali, R; Tumminia, A, 2022) |
"Rheumatic diseases were IA (60%) and CTD (40%)." | 1.56 | Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. ( Alvaro-Gracia, JM; Blanco, R; Carmona, L; Castrejón, I; Fernández Fernández, D; Fernandez-Nebro, A; Galindo, M; Gonzalez-Gay, MA; Lledó, A; Manrique-Arija, S; Martinez-Lopez, D; Mena Vázquez, N; Mera-Varela, A; Pablos, JL; Retuerto, M, 2020) |
"Obesity is associated with increased incidence and worse prognosis of more than one dozen tumor types; however, the molecular mechanisms for this association remain under debate." | 1.51 | Obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidation. ( Perry, RJ; Rabin-Court, A; Rodrigues, MR; Zhang, XM, 2019) |
"Obesity is for many scholars the most important starting status that gives rise to Metabolic Syndrome (MS) and Type 2 Diabetes (T2D)." | 1.39 | Amerindians show no association of PPAR-γ2 gene Ala12 allele and obesity: an "unthrifty" variant population genetics. ( Abd-El-Fatah-Khalil, S; Algora, M; Areces, C; Arnaiz-Villena, A; Arribas, I; Coca, C; Enríquez-de-Salamanca, M; Fernández-Honrado, M; Rey, D, 2013) |
"Obesity is a major health crisis worldwide and new treatments are needed to fight this epidemic." | 1.37 | Dietary L-arginine supplementation differentially regulates expression of lipid-metabolic genes in porcine adipose tissue and skeletal muscle. ( Gu, W; Kong, X; Li, X; Liu, Z; Smith, SB; Tan, B; Tang, W; Wu, G; Xu, H; Yao, K; Yin, Y, 2011) |
"Glycogen levels were also lower in this region." | 1.36 | Obesity and type 2 diabetes in rats are associated with altered brain glycogen and amino-acid homeostasis. ( Benie, AJ; Bouman, SD; Schousboe, A; Sickmann, HM; Waagepetersen, HS, 2010) |
"Because obesity is one of the most important risk factors for cardiovascular diseases and type 2 diabetes, obese children, who are presumably at a higher risk, may be protected from these diseases by the phenotypic effect of the Ala 12 allele on insulin resistance." | 1.33 | PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity. ( Alemanno, I; Buzzetti, R; Caiazzo, AM; Capizzi, M; di Mario, U; Mein, CA; Osborn, JA; Petrone, A; Vania, A; Zavarella, S, 2005) |
"Obesity was defined according to International Obesity Task Force." | 1.33 | PPAR-gamma2 Pro12Ala variant, insulin resistance and plasma long-chain polyunsaturated fatty acids in childhood obesity. ( Agostoni, C; Biondi, ML; Giovannini, M; Radaelli, G; Salvioni, M; Scaglioni, S; Verduci, E, 2006) |
"Insulin resistance was estimated through the homeostasis model assessment for insulin resistance method." | 1.32 | Intestinal FABP2 A54T polymorphism: association with insulin resistance and obesity in women. ( Albala, C; Angel, B; Cifuentes, M; Lera, L; Liberman, C; Pérez-Bravo, F; Santos, JL; Villarroel, AC, 2004) |
"+10 mg kg(-1) h(-1)) as pretreatments." | 1.31 | Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat. ( Arbin, V; Claperon, N; Fournié-Zaluski, MC; Peyroux, J; Roques, BP, 2001) |
"The odds ratio (95% CI) in dyslipidemia of the Thr54 allele was 1." | 1.31 | No association found between the Ala54Thr polymorphism of FABP2 gene and obesity and obesity with dyslipidemia in Japanese schoolchildren. ( Endo, K; Hamaguchi, H; Hayakawa, Y; Hirano, C; Tomura, S; Yanagi, H, 2001) |
" Oral hypoglycaemic agent dosage fell from a median of eight (IQ 6-12) to two (IQ 0-8) tablets per day (P = 0." | 1.30 | Very low calorie diet (VLCD): a useful alternative in the treatment of the obese NIDDM patient. ( Brooks, BA; Burns, CM; Capstick, F; Steinbeck, KS; Yue, DK; Zilkens, RR, 1997) |
"We studied seven obese subjects with type 2 diabetes and seven lean and seven obese control subjects (fasting plasma glucose levels, 7." | 1.30 | Glucose production, utilization, and cycling in response to moderate exercise in obese subjects with type 2 diabetes and mild hyperglycemia. ( Giacca, A; Groenewoud, Y; McClean, P; Tsui, E; Zinman, B, 1998) |
"Hyperglycemia in NIDDM compensated for insulin resistance to the extent that rates of glucose metabolism were the same as those for nondiabetics studied at euglycemia." | 1.29 | Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. ( Consoli, A; Jain, A; Kelley, DE; Mandarino, LJ, 1996) |
"Glycerol was not a major contributor to glyceride-glycerol synthesis (3." | 1.26 | A comparison of the enzyme levels and the in vitro utilization of various substrates for lipogenesis in pair-fed lean and obese pigs. ( Herbein, JH; Martin, RJ, 1976) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 50 (33.33) | 18.7374 |
1990's | 23 (15.33) | 18.2507 |
2000's | 38 (25.33) | 29.6817 |
2010's | 18 (12.00) | 24.3611 |
2020's | 21 (14.00) | 2.80 |
Authors | Studies |
---|---|
Ayodele, O | 1 |
Ren, K | 1 |
Zhao, J | 1 |
Signorovitch, J | 1 |
Jonsson Funk, M | 1 |
Zhu, J | 1 |
Bao, Y | 1 |
Gondek, K | 1 |
Keenan, H | 1 |
Ye, Z | 1 |
Zhang, C | 1 |
Wang, S | 1 |
Zhang, Y | 1 |
Li, R | 1 |
Zhao, Y | 1 |
Qiao, J | 1 |
Martino, MR | 1 |
Gutiérrez-Aguilar, M | 1 |
Yiew, NKH | 1 |
Lutkewitte, AJ | 1 |
Singer, JM | 1 |
McCommis, KS | 1 |
Ferguson, D | 1 |
Liss, KHH | 1 |
Yoshino, J | 1 |
Renkemeyer, MK | 1 |
Smith, GI | 1 |
Cho, K | 1 |
Fletcher, JA | 1 |
Klein, S | 2 |
Patti, GJ | 1 |
Burgess, SC | 1 |
Finck, BN | 1 |
Tumminia, A | 1 |
Romano, R | 1 |
Brugaletta, G | 1 |
Scicali, R | 1 |
Biondi, G | 1 |
Oliveri, R | 1 |
Romano, M | 1 |
San Lio, PM | 1 |
Atefi, M | 1 |
Entezari, MH | 1 |
Vahedi, H | 1 |
Hassanzadeh, A | 1 |
Chen, S | 1 |
Miki, T | 1 |
Fukunaga, A | 1 |
Eguchi, M | 1 |
Kochi, T | 1 |
Nanri, A | 1 |
Kabe, I | 1 |
Mizoue, T | 1 |
Jalili, V | 1 |
Poorahmadi, Z | 1 |
Hasanpour Ardekanizadeh, N | 1 |
Gholamalizadeh, M | 1 |
Ajami, M | 1 |
Houshiarrad, A | 1 |
Hajipour, A | 1 |
Shafie, F | 1 |
Alizadeh, A | 1 |
Mokhtari, Z | 1 |
Shafaei, H | 1 |
Esmaeili, M | 1 |
Doaei, S | 1 |
He, X | 1 |
Ji, N | 1 |
Huang, X | 1 |
Liu, M | 1 |
Wang, J | 1 |
Sun, T | 1 |
Sise, ME | 1 |
Baggett, MV | 1 |
Shepard, JO | 1 |
Stevens, JS | 1 |
Rhee, EP | 1 |
Azmy, V | 1 |
Benson, J | 1 |
Love, K | 1 |
Steele, R | 1 |
Wang, Y | 3 |
Foo, R | 1 |
Thum, T | 1 |
Téllez, L | 1 |
Martín Mateos, RM | 1 |
Pablos, JL | 1 |
Galindo, M | 1 |
Carmona, L | 1 |
Lledó, A | 1 |
Retuerto, M | 1 |
Blanco, R | 1 |
Gonzalez-Gay, MA | 1 |
Martinez-Lopez, D | 1 |
Castrejón, I | 1 |
Alvaro-Gracia, JM | 1 |
Fernández Fernández, D | 1 |
Mera-Varela, A | 1 |
Manrique-Arija, S | 1 |
Mena Vázquez, N | 1 |
Fernandez-Nebro, A | 1 |
Dellapiana, G | 1 |
Naqvi, M | 1 |
Leggett, C | 1 |
Tholemeier, L | 1 |
Burwick, RM | 1 |
Holeček, M | 1 |
Simmons, RM | 1 |
McKnight, SM | 1 |
Edwards, AK | 1 |
Wu, G | 3 |
Satterfield, MC | 1 |
Fikri, AM | 1 |
Smyth, R | 1 |
Kumar, V | 1 |
Al-Abadla, Z | 1 |
Abusnana, S | 1 |
Munday, MR | 1 |
Surial, B | 1 |
Mugglin, C | 1 |
Calmy, A | 1 |
Cavassini, M | 1 |
Günthard, HF | 1 |
Stöckle, M | 1 |
Bernasconi, E | 1 |
Schmid, P | 1 |
Tarr, PE | 1 |
Furrer, H | 1 |
Ledergerber, B | 1 |
Wandeler, G | 1 |
Rauch, A | 1 |
Okun, JG | 1 |
Rusu, PM | 1 |
Chan, AY | 1 |
Wu, Y | 1 |
Yap, YW | 1 |
Sharkie, T | 1 |
Schumacher, J | 1 |
Schmidt, KV | 1 |
Roberts-Thomson, KM | 1 |
Russell, RD | 1 |
Zota, A | 1 |
Hille, S | 1 |
Jungmann, A | 1 |
Maggi, L | 1 |
Lee, Y | 1 |
Blüher, M | 1 |
Herzig, S | 1 |
Keske, MA | 1 |
Heikenwalder, M | 1 |
Müller, OJ | 1 |
Rose, AJ | 1 |
Asif, S | 1 |
Baxevanidi, E | 1 |
Hill, A | 1 |
Venter, WDF | 1 |
Fairlie, L | 1 |
Masenya, M | 1 |
Serenata, C | 1 |
Sokhela, S | 1 |
Chandiwana, N | 1 |
Adachi, Y | 1 |
De Sousa-Coelho, AL | 1 |
Harata, I | 1 |
Aoun, C | 1 |
Weimer, S | 1 |
Shi, X | 1 |
Gonzalez Herrera, KN | 1 |
Takahashi, H | 1 |
Doherty, C | 1 |
Noguchi, Y | 1 |
Goodyear, LJ | 1 |
Haigis, MC | 1 |
Gerszten, RE | 1 |
Patti, ME | 1 |
Rabin-Court, A | 1 |
Rodrigues, MR | 1 |
Zhang, XM | 1 |
Perry, RJ | 1 |
Choy, K | 1 |
Nash, SH | 1 |
Kristal, AR | 1 |
Hopkins, S | 1 |
Boyer, BB | 1 |
O'Brien, DM | 1 |
de Luis, DA | 2 |
Aller, R | 2 |
Izaola, O | 3 |
Gonzalez Sagrado, M | 2 |
Conde, R | 3 |
Wang, X | 1 |
Liu, J | 1 |
Ouyang, Y | 1 |
Fang, M | 1 |
Gao, H | 1 |
Liu, L | 1 |
Yoshihara, A | 1 |
Sugita, N | 1 |
Iwasaki, M | 1 |
Miyazaki, H | 1 |
Yoshie, H | 1 |
Nakamura, K | 1 |
Araujo, TR | 1 |
Freitas, IN | 1 |
Vettorazzi, JF | 1 |
Batista, TM | 1 |
Santos-Silva, JC | 1 |
Bonfleur, ML | 1 |
Balbo, SL | 1 |
Boschero, AC | 1 |
Carneiro, EM | 1 |
Ribeiro, RA | 1 |
Johansson, LE | 1 |
Danielsson, P | 1 |
Norgren, S | 1 |
Marcus, C | 1 |
Ridderstråle, M | 1 |
Dong, CP | 1 |
He, L | 1 |
Li, JN | 1 |
Ye, F | 1 |
He, M | 1 |
Mirzaei, H | 1 |
Akrami, SM | 1 |
Golmohammadi, T | 1 |
Doosti, M | 1 |
Heshmat, R | 1 |
Nakhjavani, M | 1 |
Amiri, P | 1 |
Ben Ali, S | 1 |
Ben Yahia, F | 1 |
Sediri, Y | 1 |
Kallel, A | 1 |
Ftouhi, B | 1 |
Feki, M | 1 |
Elasmi, M | 1 |
Haj-Taieb, S | 1 |
Souheil, O | 1 |
Sanhagi, H | 1 |
Slimane, H | 1 |
Jemaa, R | 1 |
Kaabachi, N | 1 |
Sickmann, HM | 1 |
Waagepetersen, HS | 1 |
Schousboe, A | 1 |
Benie, AJ | 1 |
Bouman, SD | 1 |
Tan, B | 1 |
Yin, Y | 1 |
Liu, Z | 1 |
Tang, W | 1 |
Xu, H | 1 |
Kong, X | 1 |
Li, X | 1 |
Yao, K | 1 |
Gu, W | 1 |
Smith, SB | 1 |
Ballesteros, M | 1 |
Ruiz, E | 1 |
Cordero, M | 1 |
Muñoz, C | 1 |
Penacho, MA | 1 |
Iglesias, P | 1 |
Lopez Guzman, A | 1 |
Maldonado, A | 1 |
San Martin, L | 1 |
Puigdevall, V | 1 |
Romero, E | 1 |
Chen, CH | 1 |
Lu, ML | 1 |
Kuo, PH | 1 |
Chen, PY | 1 |
Chiu, CC | 1 |
Kao, CF | 1 |
Huang, MC | 1 |
Wang, XS | 1 |
Bai, H | 1 |
Fan, P | 1 |
Liu, R | 1 |
Liu, Y | 1 |
Liu, BW | 1 |
Jermendy, A | 1 |
Körner, A | 1 |
Kovács, M | 1 |
Madácsy, L | 1 |
Cseh, K | 1 |
Bordbar, A | 1 |
Feist, AM | 1 |
Usaite-Black, R | 1 |
Woodcock, J | 1 |
Palsson, BO | 1 |
Famili, I | 1 |
Freudenberg, A | 1 |
Petzke, KJ | 1 |
Klaus, S | 1 |
López-Alarcón, M | 1 |
Rodríguez-Cruz, M | 1 |
Vital-Reyes, VS | 1 |
Zavala-Ortega, MI | 1 |
Hinojosa-Cruz, JC | 1 |
Canizales-Quinteros, S | 1 |
Fernández, J | 1 |
de Luis, D | 1 |
Sagrado, MG | 1 |
de la Fuente, B | 1 |
Primo, D | 1 |
Arnaiz-Villena, A | 1 |
Fernández-Honrado, M | 1 |
Areces, C | 1 |
Enríquez-de-Salamanca, M | 1 |
Abd-El-Fatah-Khalil, S | 1 |
Coca, C | 1 |
Arribas, I | 1 |
Algora, M | 1 |
Rey, D | 1 |
Simón, I | 1 |
Vendrell, J | 1 |
Gutiérrez, C | 1 |
Fernández-Real, JM | 1 |
Vendrell, I | 1 |
Gallart, L | 1 |
Fontova, R | 1 |
Richart, C | 1 |
Rosmond, R | 1 |
Bouchard, C | 1 |
Björntorp, P | 1 |
Arbin, V | 2 |
Claperon, N | 2 |
Fournié-Zaluski, MC | 2 |
Roques, BP | 2 |
Peyroux, J | 2 |
McFadden, JM | 1 |
Frehywot, GL | 1 |
Townsend, CA | 1 |
Gault, VA | 1 |
O'Harte, FP | 1 |
Harriott, P | 1 |
Flatt, PR | 1 |
Rangwala, SM | 1 |
Rhoades, B | 1 |
Shapiro, JS | 1 |
Rich, AS | 1 |
Kim, JK | 1 |
Shulman, GI | 1 |
Kaestner, KH | 1 |
Lazar, MA | 1 |
Masud, S | 1 |
Ye, S | 1 |
Xita, N | 1 |
Tsatsoulis, A | 1 |
Chatzikyriakidou, A | 1 |
Georgiou, I | 1 |
Vieira-Filho, JP | 1 |
Reis, AF | 1 |
Kasamatsu, TS | 1 |
Tavares, EF | 1 |
Franco, LJ | 1 |
Matioli, SR | 1 |
Moisés, RS | 1 |
Albala, C | 1 |
Santos, JL | 1 |
Cifuentes, M | 1 |
Villarroel, AC | 1 |
Lera, L | 1 |
Liberman, C | 1 |
Angel, B | 1 |
Pérez-Bravo, F | 1 |
Wang, C | 1 |
Zhai, F | 1 |
Chi, Y | 1 |
Wang, G | 1 |
D'Adamo, M | 1 |
Perego, L | 1 |
Cardellini, M | 1 |
Marini, MA | 1 |
Frontoni, S | 1 |
Andreozzi, F | 1 |
Sciacqua, A | 1 |
Lauro, D | 1 |
Sbraccia, P | 1 |
Federici, M | 1 |
Paganelli, M | 1 |
Pontiroli, AE | 1 |
Lauro, R | 1 |
Perticone, F | 1 |
Folli, F | 1 |
Sesti, G | 1 |
Bidzińska, B | 2 |
Demissie, M | 2 |
Tworowska, U | 2 |
Slezak, R | 2 |
Dobosz, T | 2 |
Milewicz, A | 2 |
Buzzetti, R | 1 |
Petrone, A | 1 |
Caiazzo, AM | 1 |
Alemanno, I | 1 |
Zavarella, S | 1 |
Capizzi, M | 1 |
Mein, CA | 1 |
Osborn, JA | 1 |
Vania, A | 1 |
di Mario, U | 1 |
Ramis, JM | 1 |
González-Sánchez, JL | 1 |
Proenza, AM | 1 |
Martínez-Larrad, MT | 1 |
Fernández-Pérez, C | 1 |
Palou, A | 2 |
Serrano-Ríos, M | 1 |
Ghoussaini, M | 1 |
Meyre, D | 1 |
Lobbens, S | 1 |
Charpentier, G | 1 |
Clément, K | 1 |
Charles, MA | 1 |
Tauber, M | 1 |
Weill, J | 1 |
Froguel, P | 1 |
Stefański, A | 1 |
Majkowska, L | 1 |
Ciechanowicz, A | 1 |
Frankow, M | 1 |
Safranow, K | 1 |
Parczewski, M | 1 |
Moleda, P | 1 |
Pilarska, K | 1 |
Soriguer, F | 1 |
Morcillo, S | 1 |
Cardona, F | 1 |
Rojo-Martínez, G | 1 |
de la Cruz Almaráz, M | 1 |
Ruiz de Adana, Mde L | 1 |
Olveira, G | 1 |
Tinahones, F | 1 |
Esteva, I | 1 |
Scaglioni, S | 1 |
Verduci, E | 1 |
Salvioni, M | 1 |
Biondi, ML | 1 |
Radaelli, G | 1 |
Agostoni, C | 1 |
Giovannini, M | 1 |
Peeters, A | 1 |
Beckers, S | 1 |
Mertens, I | 1 |
Van Hul, W | 1 |
Van Gaal, L | 1 |
Franks, PW | 1 |
Jablonski, KA | 1 |
Delahanty, L | 1 |
Hanson, RL | 1 |
Kahn, SE | 1 |
Altshuler, D | 1 |
Knowler, WC | 1 |
Florez, JC | 1 |
Loomba, R | 1 |
Hwang, SJ | 1 |
O'Donnell, CJ | 1 |
Ellison, RC | 1 |
Vasan, RS | 1 |
D'Agostino, RB | 1 |
Liang, TJ | 1 |
Fox, CS | 1 |
Metzger, BE | 1 |
Ravnikar, V | 1 |
Vileisis, RA | 1 |
Freinkel, N | 1 |
Lombardo, YB | 1 |
Hron, WT | 1 |
Sobocinski, KA | 1 |
Menahan, LA | 1 |
Hoffer, LJ | 2 |
Bistrian, BR | 2 |
Young, VR | 2 |
Blackburn, GL | 1 |
Matthews, DE | 2 |
Minuk, HL | 1 |
Hanna, AK | 1 |
Marliss, EB | 1 |
Vranic, M | 1 |
Zinman, B | 2 |
Johnston, DG | 1 |
Alberti, KG | 2 |
Nattrass, M | 2 |
Barnes, AJ | 1 |
Bloom, SR | 1 |
Joplin, GF | 1 |
Beylot, M | 1 |
Riou, JP | 1 |
Bienvenu, F | 1 |
Mornex, R | 1 |
Naismith, DJ | 1 |
Holdsworth, MD | 1 |
Bailey, JL | 1 |
Flewitt, AP | 1 |
Emery, PW | 1 |
Swaminathan, R | 1 |
Morgan, DB | 1 |
Wales, JK | 1 |
Umpleby, AM | 1 |
Scobie, IN | 1 |
Boroujerdi, MA | 1 |
Sönksen, PH | 1 |
King, PA | 1 |
Betts, JJ | 1 |
Yebras, M | 1 |
Salvadó, J | 1 |
Arola, L | 3 |
Remesar, X | 4 |
Segués, T | 1 |
Rosebrough, RW | 1 |
Sanchís, D | 1 |
Alemany, M | 1 |
Herrero, MC | 2 |
Anglès, N | 1 |
Bladé, C | 2 |
Domènech, M | 2 |
López-Soriano, FJ | 2 |
Argilés, JM | 2 |
Clore, JN | 1 |
Blackard, WG | 1 |
Mandarino, LJ | 1 |
Consoli, A | 1 |
Jain, A | 1 |
Kelley, DE | 1 |
Andrikopoulos, S | 1 |
Proietto, J | 1 |
Vidgren, HM | 1 |
Sipiläinen, RH | 1 |
Heikkinen, S | 1 |
Laakso, M | 1 |
Uusitupa, MI | 1 |
Capstick, F | 1 |
Brooks, BA | 1 |
Burns, CM | 1 |
Zilkens, RR | 1 |
Steinbeck, KS | 1 |
Yue, DK | 1 |
Klannemark, M | 1 |
Orho, M | 1 |
Groop, L | 1 |
Giacca, A | 1 |
Groenewoud, Y | 1 |
Tsui, E | 1 |
McClean, P | 1 |
Ringel, J | 1 |
Engeli, S | 1 |
Distler, A | 1 |
Sharma, AM | 1 |
Koch, M | 1 |
Rett, K | 1 |
Maerker, E | 1 |
Volk, A | 1 |
Haist, K | 1 |
Deninger, M | 1 |
Renn, W | 1 |
Häring, HU | 1 |
Oh, EY | 1 |
Min, KM | 1 |
Chung, JH | 1 |
Min, YK | 1 |
Lee, MS | 1 |
Kim, KW | 1 |
Lee, MK | 1 |
Pratley, RE | 1 |
Baier, L | 1 |
Pan, DA | 1 |
Salbe, AD | 1 |
Storlien, L | 1 |
Ravussin, E | 1 |
Bogardus, C | 1 |
Hasstedt, SJ | 1 |
Ren, QF | 1 |
Teng, K | 1 |
Elbein, SC | 1 |
Swarbrick, MM | 1 |
Chapman, CM | 1 |
McQuillan, BM | 1 |
Hung, J | 1 |
Thompson, PL | 1 |
Beilby, JP | 1 |
Buemann, B | 1 |
Schierning, B | 1 |
Toubro, S | 1 |
Bibby, BM | 1 |
Sørensen, T | 1 |
Dalgaard, L | 1 |
Pedersen, O | 1 |
Astrup, A | 1 |
Chuang, LM | 1 |
Hsiung, CA | 1 |
Chen, YD | 1 |
Ho, LT | 1 |
Sheu, WH | 1 |
Pei, D | 1 |
Nakatsuka, CH | 1 |
Cox, D | 1 |
Pratt, RE | 1 |
Lei, HH | 1 |
Tai, TY | 1 |
Endo, K | 1 |
Yanagi, H | 1 |
Hirano, C | 1 |
Hayakawa, Y | 1 |
Hamaguchi, H | 1 |
Tomura, S | 1 |
Mentuccia, D | 1 |
Proietti-Pannunzi, L | 1 |
Tanner, K | 1 |
Bacci, V | 1 |
Pollin, TI | 1 |
Poehlman, ET | 1 |
Shuldiner, AR | 1 |
Celi, FS | 1 |
Patterson, BW | 1 |
Horowitz, JF | 1 |
Watford, M | 1 |
Coppack, SW | 1 |
Srámková, D | 1 |
Kunesová, M | 1 |
Hainer, V | 1 |
Hill, M | 1 |
Vcelák, J | 1 |
Bendlová, B | 1 |
Martin, RJ | 2 |
Gahagan, J | 1 |
Dunn, PJ | 1 |
Donald, RA | 1 |
Espiner, EA | 1 |
Redekopp, C | 1 |
Hinton, D | 1 |
Verdy, M | 1 |
Christophe, J | 1 |
Dehaye, JP | 1 |
Winand, J | 1 |
Searle, GL | 1 |
Kreutner, W | 1 |
Springer, SC | 1 |
Sherwood, JE | 1 |
Munro, HN | 1 |
Chaussain, JL | 1 |
Georges, P | 1 |
Olive, G | 1 |
Job, JC | 1 |
Felig, P | 7 |
Müller, WA | 3 |
Aoki, TT | 3 |
Cahill, GF | 5 |
Sherwin, RS | 1 |
Hendler, RG | 1 |
Herbein, JH | 1 |
Carbó, N | 1 |
Fulcher, GR | 1 |
Walker, M | 1 |
Catalano, C | 1 |
Agius, L | 1 |
Ruiz, B | 1 |
Felipe, A | 1 |
Casado, J | 1 |
Pastor-Anglada, M | 1 |
Robertson, DA | 1 |
Singh, BM | 1 |
Terrettaz, J | 1 |
Jeanrenaud, B | 1 |
Gianotti, M | 1 |
Roca, P | 1 |
Pons, A | 1 |
Asano, T | 1 |
Ninomiya, H | 1 |
Kan, K | 1 |
Yamamoto, T | 1 |
Okumura, M | 1 |
Kowalchuk, JM | 1 |
Curi, R | 1 |
Newsholme, EA | 1 |
Yang, RD | 1 |
Bier, DM | 1 |
Kalderon, B | 1 |
Gutman, A | 1 |
Levy, E | 1 |
Shafrir, E | 1 |
Adler, JH | 1 |
Castillo, M | 1 |
Scheen, A | 1 |
Lefebvre, PJ | 1 |
Luyckx, AS | 1 |
Elliott, J | 2 |
Dade, E | 1 |
Salmon, DM | 1 |
Hems, DA | 2 |
Hellman, B | 3 |
Sehlin, J | 4 |
Täljedal, IB | 2 |
Schainker, B | 1 |
Olney, JW | 1 |
Brennan, MF | 2 |
Genuth, SM | 2 |
Castro, JH | 1 |
Vertes, V | 1 |
Wise, JK | 3 |
Hendler, R | 3 |
Gylfe, E | 1 |
Huchzermeyer, H | 1 |
Rudorff, KH | 1 |
Staib, W | 1 |
Marliss, E | 2 |
Owen, OE | 1 |
Hellerström, C | 1 |
Westman, S | 1 |
Stork, H | 1 |
Schmidt, FH | 1 |
Täljedal, I | 1 |
Beloff-Chain, A | 1 |
Pozefsky, T | 1 |
Adibi, SA | 3 |
Drash, AL | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
[NCT00004992] | Phase 3 | 3,234 participants (Actual) | Interventional | 1996-07-31 | Completed | ||
Do Preoperative Carbohydrate Drinks Prevent Preoperative Catabolism in Mothers Undergoing Elective Caesarean Section? A Randomised Controlled Study[NCT03220997] | 200 participants (Anticipated) | Interventional | 2017-08-31 | Not yet recruiting | |||
Effects of Very Low Calorie Ketogenic Diet on Microbiota, Adipose Tissue and Immunitary Regulation: Pilot Study on Patients With Metabolic Syndrome[NCT05275608] | 40 participants (Anticipated) | Interventional | 2022-11-07 | Recruiting | |||
Modulation of Insulin Secretion and Insulin Sensitivity in Bangladeshi Type 2 Diabetic Subjects by an Insulin Sensitizer Pioglitazone and T2DM Association With PPARG Gene Polymorphism.[NCT01589445] | Phase 4 | 77 participants (Actual) | Interventional | 2008-11-30 | Completed | ||
[NCT00005270] | 0 participants | Observational | 1995-09-30 | Completed | |||
Thyroid Hormone-Induced Lipolysis: An In Vivo Microdialysis Study[NCT00312715] | 41 participants (Actual) | Observational | 2006-04-03 | Completed | |||
Effects of Pharmacologic Block of Type-1 Deiodinase on Thyroid Hormone Action and on the Circulating Levels of T3 in Hypothyroid Patients[NCT01801033] | 0 participants (Actual) | Observational | 2013-01-04 | Withdrawn | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Response rate was defined by ≥10% decrease of FSG or/and ≥1% decrease of HbA1c from the baseline values after 3 months treatment.48 responded to pioglitazone and 32 responded to metformin. (NCT01589445)
Timeframe: 3 months for each drug
Intervention | mmol/l (Mean) | |
---|---|---|
Baseline FSG | 3rd Month FSG | |
Metformin ( 002 Group) | 6.2 | 6.5 |
Pioglitazone (001 Group) | 6.9 | 5.4 |
Response rate was defined by ≥10% decrease of FSG or/and ≥1% decrease of HbA1c from the baseline values after 3 months treatment.48 responded to pioglitazone and 32 responded to metformin. (NCT01589445)
Timeframe: 3 months for each drug
Intervention | μU/ml (Mean) | |
---|---|---|
Baseline FSI | 3rd month FSI | |
Metformin ( 002 Group) | 13.0 | 13.9 |
Pioglitazone (001 Group) | 16.2 | 12.3 |
Response rate was defined by ≥10% decrease of FSG or/and ≥1% decrease of HbA1c from the baseline values after 3 months treatment.48 responded to pioglitazone and 32 responded to metformin. (NCT01589445)
Timeframe: 3 months for each drug
Intervention | percentage (Mean) | |
---|---|---|
Baseline HbA1c | 3rd month HbA1c | |
Metformin ( 002 Group) | 7.8 | 7.0 |
Pioglitazone (001 Group) | 7.3 | 6.7 |
"Response rate was defined by ≥10% decrease of FSG or/and ≥1% decrease of HbA1c from the baseline values after 3 months treatment.48 responded to pioglitazone and 32 responded to metformin.~Analysis 1: Homeostatic Model Assessment of Beta cell function(HOMA percent B) Analysis 2: Homeostatic Model Assessment of Insulin Sensitivity (Homa percent S)" (NCT01589445)
Timeframe: 3 months for each drug
Intervention | percentage (Mean) | |||
---|---|---|---|---|
Baseline HOMA percent beta cells function | 3rd month HOMA percent beta cells function | Baseline HOMA percent sensitivity | 3rd month HOMA percent sensitivity | |
Metformin ( 002 Group) | 109.3 | 116.0 | 76.2 | 67.2 |
Pioglitazone (001 Group) | 118.9 | 132.3 | 51.1 | 69.3 |
"Response rate was defined by ≥10% decrease of FSG or/and ≥1% decrease of HbA1c from the baseline values after 3 months treatment.48 responded to pioglitazone and 32 responded to metformin.~Analysis 1: Homeostasis Model Assessment Insulin Resistance(HOMA IR) Analysis 2: Quantitative Insulin sensitivity Check Index(QUICKI)" (NCT01589445)
Timeframe: 3 months for each drug
Intervention | Score on a scale ( SI unit) (Mean) | |||
---|---|---|---|---|
Baseline QUICKI | 3rd month QUICKI | Baseline HOMA IR | 3rd month HOMA IR | |
Metformin ( 002 Group) | 0.57 | 0.54 | 3.7 | 4.3 |
Pioglitazone (001 Group) | 0.52 | 0.59 | 5.1 | 2.9 |
"Response rate was defined by ≥10% decrease of FSG or/and ≥1% decrease of HbA1c from the baseline values after 3 months treatment.48 responded to pioglitazone and 32 responded to metformin.~Analysis 1:Total Cholesterol(TC) Analysis 2:Triglyceride(TG) Analysis 3:High Density Lipoprotein(HDL) Analysis 4:Low Density Lipoprotein(LDL)" (NCT01589445)
Timeframe: 3 months for each drug
Intervention | mg/dl (Mean) | |||||||
---|---|---|---|---|---|---|---|---|
Baseline TC | 3rd month TC | Baseline TG | 3rd month TG | Baseline HDL | 3rd month HDL | Baseline LDL | 3rd month LDL | |
Metformin (002 Group) | 193.0 | 177.0 | 166.0 | 175.0 | 34.4 | 34.7 | 125.6 | 112.0 |
Pioglitazone (001 Group) | 182.0 | 178 | 183 | 195 | 33 | 33.2 | 112.8 | 105.5 |
9 reviews available for alanine and Obesity
Article | Year |
---|---|
COVID-19 and liver disease: An update.
Topics: Adenosine Monophosphate; Age Factors; Alanine; Antiviral Agents; Betacoronavirus; Bile Ducts; Chemic | 2020 |
Why Are Branched-Chain Amino Acids Increased in Starvation and Diabetes?
Topics: Alanine; Amino Acids, Branched-Chain; Diabetes Mellitus; Fatty Acids; Female; Glycolysis; Humans; In | 2020 |
The predicted risk of adverse pregnancy outcomes as a result of treatment-associated obesity in a hypothetical population receiving tenofovir alafenamide/emtricitabine/dolutegravir, tenofovir disoproxil fumarate/emtricitabine/dolutegravir or tenofovir dis
Topics: Alanine; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Emtricitabine; Female; Heterocyclic | 2021 |
Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis.
Topics: Alanine; Body Mass Index; Cohort Studies; Coronary Artery Disease; Female; Genotype; Humans; Male; O | 2003 |
The use of isotope turnover techniques in the study of carbohydrate metabolism in man.
Topics: Acromegaly; Alanine; Blood Glucose; Carbohydrate Metabolism; Carbon Dioxide; Carbon Isotopes; Ethano | 1976 |
Amino acid metabolism in man.
Topics: Alanine; Amino Acids; Brain; Diabetes Mellitus; Erythrocytes; Glucagon; Glucocorticoids; Gluconeogen | 1975 |
Metabolic effects of glucocorticoids in man.
Topics: Adolescent; Adult; Alanine; Amino Acids; Blood Glucose; Cortisone; Cushing Syndrome; Dexamethasone; | 1974 |
Blood glucose and cluconeogenesis in fasting man.
Topics: Adult; Alanine; Amino Acids; Blood Glucose; Brain; Fasting; Female; Gluconeogenesis; Homeostasis; Hu | 1969 |
Interactions between carbohydrate, protein, and fat metabolism in starvation.
Topics: Alanine; Amino Acids; Ammonia; Carbohydrate Metabolism; Gluconeogenesis; Glycerol; Glycine; Humans; | 1969 |
6 trials available for alanine and Obesity
Article | Year |
---|---|
Sesame Oil Ameliorates Alanine Aminotransferase, Aspartate Aminotransferase, and Fatty Liver Grade in Women with Nonalcoholic Fatty Liver Disease Undergoing Low-Calorie Diet: A Randomized Double-Blind Controlled Trial.
Topics: Alanine; Alanine Transaminase; Aspartate Aminotransferases; Caloric Restriction; Diet, Reducing; Fem | 2022 |
Fatty acid-binding protein 2 Ala54Thr genotype is associated with insulin resistance and leptin levels changes after a high monounsaturated fat diet in obese non-diabetic patients.
Topics: Adult; Alanine; Amino Acid Substitution; Diet, High-Fat; Dietary Fats, Unsaturated; Fatty Acid-Bindi | 2013 |
The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program.
Topics: Adult; Alanine; Amino Acid Substitution; Body Composition; Chromans; Diabetes Mellitus, Type 2; Diet | 2007 |
Metabolic effects of very low calorie weight reduction diets.
Topics: Alanine; Amino Acids; Diet, Reducing; Energy Intake; Female; Humans; Leucine; Nitrogen; Obesity | 1984 |
Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects.
Topics: 3-Hydroxybutyric Acid; Alanine; Blood Glucose; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Ty | 1992 |
Alanine flux in obese and healthy humans as evaluated by 15N- and 2H3-labeled alanines.
Topics: Adult; Alanine; Amino Acids; Female; Gas Chromatography-Mass Spectrometry; Humans; Infusions, Intrav | 1988 |
135 other studies available for alanine and Obesity
Article | Year |
---|---|
Real-world treatment patterns and clinical outcomes for inpatients with COVID-19 in the US from September 2020 to February 2021.
Topics: Adenosine Monophosphate; Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Anti-Inflammatory Agen | 2021 |
Amino acid signatures in relation to polycystic ovary syndrome and increased risk of different metabolic disturbances.
Topics: Alanine; Amino Acids; Body Mass Index; Female; Glycine; Humans; Insulin Resistance; Lysine; Metaboli | 2022 |
Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids.
Topics: Alanine; Alanine Transaminase; Amino Acids; Animals; Diabetes Mellitus; Gluconeogenesis; Glucose; Hu | 2022 |
The impact of obesity and dyslipidemia on Remdesivir effectiveness in hospitalized patients with SARS-CoV-2-related pneumonia: An observational study.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19 Drug Treatment; Dyslipidemias; Humans; | 2022 |
Associations of serum amino acids with insulin resistance among people with and without overweight or obesity: A prospective study in Japan.
Topics: Alanine; Animals; Humans; Insulin; Insulin Resistance; Isoleucine; Japan; Methionine; Obesity; Overw | 2022 |
The association between obesity with serum levels of liver enzymes, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and gamma-glutamyl transferase in adult women.
Topics: Adult; Alanine; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Cross-Secti | 2022 |
[Plasma amino acids levels in 1859 physical examination subjects in Hangzhou City in 2020].
Topics: Alanine; Amino Acids; Chromatography, Liquid; Female; Humans; Leucine; Male; Methionine; Middle Aged | 2022 |
Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury.
Topics: Acute Kidney Injury; Adenosine Monophosphate; Aged; Alanine; Amides; Anti-Inflammatory Agents; Antic | 2020 |
Idiopathic nonhistaminergic acquired angioedema in a patient with coronavirus disease 2019.
Topics: Adenosine Monophosphate; Adult; Alanine; Ampicillin; Angioedema; Betacoronavirus; Coronavirus Infect | 2020 |
Using "old" medications to fight new COVID-19: Re-purposing with a purpose.
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Betaco | 2020 |
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
Topics: Adenosine Monophosphate; Age Factors; Aged; Alanine; Antiviral Agents; Arthritis, Psoriatic; Arthrit | 2020 |
Preferential use of dexamethasone for fetal lung maturation in severe coronavirus disease 2019.
Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Compassionate Use Trials; COVID-19; Dexam | 2020 |
Obesity increases hepatic glycine dehydrogenase and aminomethyltransferase expression while dietary glycine supplementation reduces white adipose tissue in Zucker diabetic fatty rats.
Topics: Adipose Tissue, White; Alanine; Aminomethyltransferase; Animals; Appetite Regulation; Body Weight; D | 2020 |
Pre-diagnostic biomarkers of type 2 diabetes identified in the UAE's obese national population using targeted metabolomics.
Topics: 3-Hydroxybutyric Acid; Adult; Alanine; Amino Acids, Branched-Chain; Biomarkers; Chromatography, Liqu | 2020 |
Summary for Patients: Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV.
Topics: Adult; Alanine; Anti-HIV Agents; HIV Infections; Humans; Lipids; Obesity; Tenofovir; Weight Gain | 2021 |
Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV : A Cohort Study.
Topics: Adult; Alanine; Anti-HIV Agents; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Fem | 2021 |
Liver alanine catabolism promotes skeletal muscle atrophy and hyperglycaemia in type 2 diabetes.
Topics: Alanine; Alanine Transaminase; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, An | 2021 |
l-Alanine activates hepatic AMP-activated protein kinase and modulates systemic glucose metabolism.
Topics: Adenosine Triphosphate; Alanine; Amino Acids; AMP-Activated Protein Kinases; Animals; Carbohydrate M | 2018 |
Obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidation.
Topics: Alanine; Breast Neoplasms; Cell Line, Tumor; Citrate (si)-Synthase; Colonic Neoplasms; Female; Gene | 2019 |
The carbon isotope ratio of alanine in red blood cells is a new candidate biomarker of sugar-sweetened beverage intake.
Topics: Adolescent; Adult; Alanine; Alaska; Beverages; Biomarkers; Body Mass Index; Carbon Isotopes; Diet; D | 2013 |
The association between the Pro12Ala variant in the PPARγ2 gene and type 2 diabetes mellitus and obesity in a Chinese population.
Topics: Adult; Alanine; Amino Acid Substitution; Asian People; Blood Glucose; Body Mass Index; China; Diabet | 2013 |
The Interaction Between β-3 Adrenergic Receptor and Peroxisome Proliferator-Activated Receptor Gamma Gene Polymorphism to Periodontal Disease in Community-Dwelling Elderly Japanese.
Topics: Aged; Alanine; Arginine; Body Mass Index; C-Reactive Protein; Epistasis, Genetic; Female; Gene-Envir | 2015 |
Benefits of L-alanine or L-arginine supplementation against adiposity and glucose intolerance in monosodium glutamate-induced obesity.
Topics: Adiposity; Alanine; Animals; Arginine; Blood Glucose; Cholesterol; Dietary Supplements; Gene Express | 2017 |
Interaction between PPARG Pro12Ala and ADIPOQ G276T concerning cholesterol levels in childhood obesity.
Topics: Adiponectin; Adolescent; Alanine; Body Mass Index; Child; Cholesterol; Cross-Sectional Studies; Fema | 2009 |
[Association of the Pro12Ala and C1431T polymorphism of the PPAR gamma2 gene and their haplotypes with obesity and type 2 diabetes].
Topics: Alanine; Amino Acid Substitution; Asian People; Diabetes Mellitus, Type 2; Female; Gene Frequency; G | 2008 |
Polymorphism of Pro12Ala in the peroxisome proliferator-activated receptor gamma2 gene in Iranian diabetic and obese subjects.
Topics: Alanine; Asian People; Body Mass Index; Case-Control Studies; Cross-Sectional Studies; Diabetes Mell | 2009 |
Gender-specific effect of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma-2 gene on obesity risk and leptin levels in a Tunisian population.
Topics: Alanine; Case-Control Studies; Female; Humans; Leptin; Male; Obesity; PPAR gamma; Proline; Risk Fact | 2009 |
Obesity and type 2 diabetes in rats are associated with altered brain glycogen and amino-acid homeostasis.
Topics: Alanine; Amino Acids; Animals; Aspartic Acid; Blood Glucose; Brain; Diabetes Mellitus, Type 2; gamma | 2010 |
Dietary L-arginine supplementation differentially regulates expression of lipid-metabolic genes in porcine adipose tissue and skeletal muscle.
Topics: Acetyl-CoA Carboxylase; Adipose Tissue, White; Alanine; Animals; Arginine; Chemical Phenomena; Dieta | 2011 |
Polymorphism Ala54Thr of fatty acid-binding protein 2: Allelic frequencies and influence on cardiovascular risk factors in a multicenter study of Castilla y Leon.
Topics: Adult; Alanine; Anthropometry; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cross-S | 2010 |
Gender differences in the effects of peroxisome proliferator-activated receptor γ2 gene polymorphisms on metabolic adversity in patients with schizophrenia or schizoaffective disorder.
Topics: Adult; Alanine; Female; Gene Frequency; Genotype; Humans; Male; Metabolic Diseases; Metabolic Syndro | 2011 |
[Analysis of the FABP2 gene Ala54Thr polymorphism in non-obese and obese Chinese].
Topics: Aged; Alanine; Asian People; Cholesterol, HDL; Fatty Acid-Binding Proteins; Female; Humans; Male; Mi | 2011 |
PPAR-gamma2 pro12Ala polymorphism is associated with post-challenge abnormalities of glucose homeostasis in children and adolescents with obesity.
Topics: Adolescent; Alanine; Amino Acid Substitution; Child; Cohort Studies; Diabetes Mellitus, Type 2; Fema | 2011 |
A multi-tissue type genome-scale metabolic network for analysis of whole-body systems physiology.
Topics: Adipocytes; Alanine; Computer Simulation; Diabetes Mellitus; Genome, Human; Hepatocytes; Humans; Met | 2011 |
Dietary L-leucine and L-alanine supplementation have similar acute effects in the prevention of high-fat diet-induced obesity.
Topics: Alanine; Animals; Blood Glucose; Diet, High-Fat; Dietary Proteins; Dietary Supplements; Humans; Insu | 2013 |
PPARγ2 Pro12Ala polymorphism is associated with improved lipoprotein lipase functioning in adipose tissue of insulin resistant obese women.
Topics: Adipose Tissue; Adult; Alanine; Base Sequence; DNA Primers; Female; Humans; Insulin Resistance; Lipo | 2012 |
Effect of fatty acid-binding protein 2 Ala54Thr genotype on weight loss and cardiovascular risk factors after a high-polyunsaturated fat diet in obese patients.
Topics: Adult; Alanine; Caloric Restriction; Cardiovascular Diseases; Dietary Fats, Unsaturated; Fatty Acid- | 2012 |
Amerindians show no association of PPAR-γ2 gene Ala12 allele and obesity: an "unthrifty" variant population genetics.
Topics: Adult; Aged; Alanine; Amino Acid Substitution; Female; Gene Frequency; Genetic Association Studies; | 2013 |
Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma is associated with increased leptin levels in women with type-2 diabetes mellitus.
Topics: Aged; Alanine; Alleles; Antigens, CD; Body Mass Index; Cytokines; Diabetes Mellitus, Type 2; Female; | 2002 |
Lack of association between the uncoupling protein-2 Ala55Val gene polymorphism and phenotypic features of the Metabolic Syndrome.
Topics: Alanine; Alleles; Blood Glucose; Blood Pressure; Humans; Insulin; Ion Channels; Male; Membrane Trans | 2002 |
Effects of dual angiotensin-converting enzyme and neutral endopeptidase 24-11 chronic inhibition by mixanpril on insulin sensitivity in lean and obese Zucker rats.
Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Flow Velocity; Blood Glucose; Capt | 2003 |
A flexible route to (5R)-thiolactomycin, a naturally occurring inhibitor of fatty acid synthesis.
Topics: Acetyltransferases; Alanine; Anti-Bacterial Agents; Fatty Acid Synthase, Type II; Fatty Acids; Human | 2002 |
Degradation, cyclic adenosine monophosphate production, insulin secretion, and glycemic effects of two novel N-terminal Ala2-substituted analogs of glucose-dependent insulinotropic polypeptide with preserved biological activity in vivo.
Topics: Alanine; Amino Acid Substitution; Aminobutyrates; Animals; Blood; Cell Line; Cricetinae; Cricetulus; | 2003 |
Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity.
Topics: Adiponectin; Adipose Tissue; Adipose Tissue, Brown; Alanine; Amino Acid Substitution; Animals; Blood | 2003 |
Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG serum levels.
Topics: Adult; Alanine; Alleles; DNA; Female; Gene Frequency; Genotype; Humans; Obesity; Polycystic Ovary Sy | 2003 |
Influence of the polymorphisms Tpr64Arg in the beta 3-adrenergic receptor gene and Pro12Ala in the PPAR gamma 2 gene on metabolic syndrome-related phenotypes in an indigenous population of the Brazilian Amazon.
Topics: Alanine; Arginine; Brazil; Female; Humans; Male; Metabolic Syndrome; Obesity; Phenotype; Polymorphis | 2004 |
Intestinal FABP2 A54T polymorphism: association with insulin resistance and obesity in women.
Topics: Adult; Alanine; Alleles; Body Mass Index; Carrier Proteins; Fatty Acid-Binding Proteins; Female; Gen | 2004 |
[Association of Pro12Ala mutation in peroxisome proliferator-activated receptor gamma 2 with obesity and diabetes in Chinese population].
Topics: Adult; Alanine; Diabetes Mellitus; Female; Gene Frequency; Humans; Male; Mutation; Obesity; Polymorp | 2004 |
The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes.
Topics: Adipose Tissue; Adult; Alanine; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Genotype; G | 2004 |
[Is obesity associated with a polymorphism Pro12Ala and Pro115Gln in PPARgamma gene?].
Topics: Alanine; Case-Control Studies; Female; Glutamine; Heterozygote; Homozygote; Humans; Male; Obesity; P | 2004 |
PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity.
Topics: Adolescent; Alanine; Child; Exons; Female; Genetic Variation; Genotype; Humans; Insulin; Insulin Res | 2005 |
The Arg64 allele of the beta 3-adrenoceptor gene but not the -3826G allele of the uncoupling protein 1 gene is associated with increased leptin levels in the Spanish population.
Topics: Adipocytes; Adult; Alanine; Arginine; Blood Glucose; Body Mass Index; Carrier Proteins; Cholesterol; | 2004 |
[Is obesity associated with a polymorphism Pro12Ala and Pro115Gln in the PPARgamma gene?].
Topics: Alanine; Body Mass Index; Case-Control Studies; Female; Gene Frequency; Glycine; Humans; Male; Obesi | 2004 |
Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population.
Topics: Adolescent; Adult; Alanine; Amino Acid Substitution; Case-Control Studies; Child; Diabetes Mellitus, | 2005 |
Association between the Pro12Ala variant of the peroxisome proliferator-activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with type II diabetes.
Topics: Alanine; Alleles; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Female; Humans; Hypert | 2006 |
Pro12Ala polymorphism of the PPARG2 gene is associated with type 2 diabetes mellitus and peripheral insulin sensitivity in a population with a high intake of oleic acid.
Topics: Adolescent; Adult; Aged; Alanine; Alleles; Body Mass Index; Cross-Sectional Studies; Diabetes Mellit | 2006 |
PPAR-gamma2 Pro12Ala variant, insulin resistance and plasma long-chain polyunsaturated fatty acids in childhood obesity.
Topics: Alanine; Child; Fatty Acids, Unsaturated; Female; Gene Frequency; Humans; Insulin Resistance; Male; | 2006 |
The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men.
Topics: Abdominal Fat; Adiposity; Adult; Alanine; Case-Control Studies; Female; Glycine; Humans; Male; Middl | 2007 |
Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study.
Topics: Adult; Age of Onset; Alanine; Aspartate Aminotransferases; Biomarkers; Cardiovascular Diseases; Fema | 2008 |
"Accelerated starvation" and the skipped breakfast in late normal pregnancy.
Topics: 3-Hydroxybutyric Acid; Alanine; Blood Glucose; Diabetes Mellitus; Fasting; Fatty Acids, Nonesterifie | 1982 |
A metabolic profile of fed and fasting genetically obese mice at 4-5 months of age.
Topics: Alanine; Animals; Blood Glucose; Carbohydrate Metabolism; Diet; Fatty Acids, Nonesterified; Insulin | 1984 |
Metabolic response to moderate exercise in obese man during prolonged fasting.
Topics: Adult; Alanine; Blood Glucose; Fasting; Fatty Acids, Nonesterified; Female; Glycogen; Heart Rate; Hu | 1980 |
Hormonal and metabolic rhythms in Cushing's syndrome.
Topics: Adolescent; Adult; Alanine; Blood Glucose; Circadian Rhythm; Cushing Syndrome; Fatty Acids, Nonester | 1980 |
Increased ketonaemia in hyperthyroidism. Evidence for a beta-adrenergic mechanism.
Topics: Adult; Aged; Alanine; Blood Glucose; Diet, Reducing; Energy Intake; Female; Glucagon; Glycerol; Huma | 1980 |
Carbohydrate conservation in the obese: a theory to explain the ease of weight gain.
Topics: Adult; Alanine; Blood Glucose; Body Composition; Body Weight; Dietary Carbohydrates; Energy Intake; | 1982 |
Effect of fasting on the disappearance of injected alanine and 3-hydroxybutyrate in obese subjects.
Topics: 3-Hydroxybutyric Acid; Adult; Aged; Alanine; Blood Glucose; Fasting; Female; Half-Life; Humans; Hydr | 1982 |
The effect of starvation on leucine, alanine and glucose metabolism in obese subjects.
Topics: Adult; Alanine; Fatty Acids, Nonesterified; Female; Glucose; Humans; Insulin; Leucine; Male; Metabol | 1995 |
Insulin and Na-dependent alanine transport in skeletal muscle of obese Zucker (fa/fa) rats.
Topics: Alanine; Animals; Biological Transport; Blood Glucose; Body Weight; Cell Membrane; Insulin; Kinetics | 1994 |
Changes in alanine turnover rate due to nutritional and genetic obesity in the rat.
Topics: Alanine; Analysis of Variance; Animals; Body Weight; Diet; Disease Models, Animal; Energy Intake; Ma | 1994 |
In vitro substrate utilization for lipid synthesis in liver explants from hyperthyroid chickens.
Topics: Acetates; Alanine; Animals; Carbon Dioxide; Chickens; Diet; Dietary Proteins; Growth; Hyperthyroidis | 1993 |
L-alanine transport in small intestine brush-border membrane vesicles of obese rats.
Topics: Alanine; Animals; Biological Transport; Diet; Intestine, Small; Kinetics; Microvilli; Obesity; Rats; | 1994 |
Splanchnic ammonia management in genetic and dietary obesity in the rat.
Topics: Alanine; Ammonia; Animals; Aorta; Diet; Fasting; Glutamine; Hepatic Veins; Liver; Male; Obesity; Por | 1994 |
Alanine as a lipogenic precursor in isolated hepatocytes from obese Zucker rats.
Topics: Acetyl Coenzyme A; Alanine; Alanine Transaminase; Animals; Cells, Cultured; Citrates; Coumaric Acids | 1993 |
Suppression of gluconeogenesis after a 3-day fast does not deplete liver glycogen in patients with NIDDM.
Topics: Adult; Alanine; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Ethanol; Fasting; Fatty | 1994 |
Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM.
Topics: Adult; Alanine; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Energy Metabolism; Fatt | 1996 |
The biochemical basis of increased hepatic glucose production in a mouse model of type 2 (non-insulin-dependent) diabetes mellitus.
Topics: Alanine; Animals; Body Mass Index; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dietary Fats; Disea | 1995 |
Threonine allele in codon 54 of the fatty acid binding protein 2 gene does not modify the fatty acid composition of serum lipids in obese subjects.
Topics: Adult; Alanine; Alleles; Carrier Proteins; Codon; Fatty Acid-Binding Protein 7; Fatty Acid-Binding P | 1997 |
Very low calorie diet (VLCD): a useful alternative in the treatment of the obese NIDDM patient.
Topics: Adult; Alanine; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus; Diabetes Mellitus, Ty | 1997 |
No relationship between identified variants in the uncoupling protein 2 gene and energy expenditure.
Topics: Aged; Alanine; Amino Acid Substitution; Energy Metabolism; Exons; Female; Genetic Variation; Genotyp | 1998 |
Glucose production, utilization, and cycling in response to moderate exercise in obese subjects with type 2 diabetes and mild hyperglycemia.
Topics: Adult; Alanine; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Exercise; Fe | 1998 |
Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus.
Topics: Adult; Alanine; Amino Acid Substitution; Cholesterol; Codon; Coronary Disease; Diabetes Mellitus; Di | 1999 |
The PPARgamma2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of Type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects.
Topics: Adult; Alanine; Amino Acid Substitution; Codon; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female | 1999 |
Ammonium uptake and urea production in hepatocytes from lean and obese Zucker rats.
Topics: Alanine; Animals; Biological Transport, Active; In Vitro Techniques; Liver; Male; Nitrogen; Obesity; | 1999 |
Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects.
Topics: Alanine; Amino Acid Substitution; Asian People; Body Mass Index; Diabetes Mellitus; Female; Genotype | 2000 |
Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans.
Topics: Adipose Tissue; Adult; Alanine; Carrier Proteins; Dietary Fats; Fatty Acid-Binding Protein 7; Fatty | 2000 |
Effect of the peroxisome proliferator-activated receptor-gamma 2 pro(12)ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds.
Topics: Alanine; Amino Acid Substitution; Blood Glucose; Blood Pressure; Body Mass Index; Chromosomes, Human | 2001 |
A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.
Topics: Aging; Alanine; Alleles; Amino Acid Substitution; Anthropometry; Australia; Blood Pressure; Choleste | 2001 |
The association between the val/ala-55 polymorphism of the uncoupling protein 2 gene and exercise efficiency.
Topics: Adult; Alanine; Calorimetry, Indirect; Energy Metabolism; Exercise; Exercise Test; Female; Genotype; | 2001 |
Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat.
Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; | 2001 |
Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance.
Topics: Adult; Age Factors; Aged; Alanine; Alleles; Blood Glucose; China; Family Health; Female; Genotype; G | 2001 |
Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance.
Topics: Adult; Age Factors; Aged; Alanine; Alleles; Blood Glucose; China; Family Health; Female; Genotype; G | 2001 |
Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance.
Topics: Adult; Age Factors; Aged; Alanine; Alleles; Blood Glucose; China; Family Health; Female; Genotype; G | 2001 |
Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance.
Topics: Adult; Age Factors; Aged; Alanine; Alleles; Blood Glucose; China; Family Health; Female; Genotype; G | 2001 |
No association found between the Ala54Thr polymorphism of FABP2 gene and obesity and obesity with dyslipidemia in Japanese schoolchildren.
Topics: Adolescent; Alanine; Base Sequence; Carrier Proteins; Child; DNA Primers; Fatty Acid-Binding Protein | 2001 |
Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3-adrenergic receptor.
Topics: Alanine; Blood Glucose; Glucose Clamp Technique; Heterozygote; Homozygote; Humans; Insulin; Insulin | 2002 |
Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3-adrenergic receptor.
Topics: Alanine; Blood Glucose; Glucose Clamp Technique; Heterozygote; Homozygote; Humans; Insulin; Insulin | 2002 |
Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3-adrenergic receptor.
Topics: Alanine; Blood Glucose; Glucose Clamp Technique; Heterozygote; Homozygote; Humans; Insulin; Insulin | 2002 |
Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3-adrenergic receptor.
Topics: Alanine; Blood Glucose; Glucose Clamp Technique; Heterozygote; Homozygote; Humans; Insulin; Insulin | 2002 |
Regional muscle and adipose tissue amino acid metabolism in lean and obese women.
Topics: Abdomen; Adipose Tissue; Adult; Alanine; Amino Acids; Arteries; Body Composition; Body Constitution; | 2002 |
Is a Pro12Ala polymorphism of the PPARgamma2 gene related to obesity and type 2 diabetes mellitus in the Czech population?
Topics: Adult; Alanine; Case-Control Studies; Czechoslovakia; Diabetes Mellitus, Type 2; Female; Genetics, P | 2002 |
Serum hormone levels and tissue metabolism in pair-fed lean and obese Zucker rats.
Topics: Adipose Tissue; Alanine; Animals; Cyclic AMP; Fatty Acids; Female; Glucagon; Gluconeogenesis; Glycol | 1977 |
The influence of glucagon on sodium retention after fasting.
Topics: Adolescent; Adult; Alanine; Diet; Fasting; Female; Glucagon; Glucose; Humans; Middle Aged; Obesity; | 1977 |
Sodium sparing effect of alanine in fasting obese females.
Topics: Adult; Alanine; Fasting; Female; Humans; Obesity; Potassium; Renin; Sodium | 1979 |
Experimental basis of obesity.
Topics: Acetates; Adenylyl Cyclases; Adipose Tissue; Alanine; Animals; Dietary Carbohydrates; Dietary Fats; | 1978 |
Resistance of gluconeogenic and glycogenic pathways in obese-hyperglycemic mice.
Topics: Alanine; Animals; Enzyme Activation; Female; Genotype; Gluconeogenesis; Glucose Tolerance Test; Glyc | 1975 |
Regulation of protein metabolism in relation to adequacy of intake.
Topics: Adaptation, Physiological; Alanine; Amino Acids; Dietary Proteins; Fasting; Gluconeogenesis; Glutama | 1975 |
Effect of 24 hour fast in obese children.
Topics: Adolescent; Alanine; Blood Glucose; Child; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Gr | 1976 |
Effect of alanine and glycine on glucagon secretion in postabsorptive and fasting obese man.
Topics: Adolescent; Adult; Alanine; Blood Glucose; Fasting; Female; Glucagon; Glycine; Humans; Insulin; Male | 1975 |
Effect of ketone infusions on amino acid and nitrogen metabolism in man.
Topics: Adult; Alanine; Amino Acids; Blood Glucose; Fasting; Female; Glucagon; Humans; Hydroxybutyrates; Inf | 1975 |
A comparison of the enzyme levels and the in vitro utilization of various substrates for lipogenesis in pair-fed lean and obese pigs.
Topics: Acetates; Adipose Tissue; Alanine; Animals; Gluconeogenesis; Glucose; Glycerol; Glycolysis; Leucine; | 1976 |
The metabolic fate of an oral 14C-alanine load in the obese Zucker rat.
Topics: Adipose Tissue; Adipose Tissue, Brown; Administration, Oral; Alanine; Animals; Female; Food Deprivat | 1992 |
Amino acid uptake by liver of genetically obese Zucker rats.
Topics: Alanine; Animals; Biological Transport; Cell Membrane; DNA; Glutamate-Ammonia Ligase; Glutaminase; G | 1991 |
Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
Topics: Adult; Alanine; Blood Glucose; Body Mass Index; C-Peptide; Fatty Acids, Nonesterified; Female; Gluco | 1991 |
Contribution of glycerol and alanine to basal hepatic glucose production in the genetically obese (fa/fa) rat.
Topics: Alanine; Animals; Glucose; Glycerol; Liver; Liver Glycogen; Metabolic Clearance Rate; Obesity; Rats; | 1990 |
In vivo C14-L-alanine metabolism in rat dietary obesity induced by cafeteria diet.
Topics: Alanine; Amino Acids; Animals; Blood Glucose; Diet; Female; Food Deprivation; Glucose; Glycogen; Lac | 1990 |
Plasma glucagon response to intravenous alanine in obese and non-obese subjects.
Topics: Alanine; Fatty Acids; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Obesity; Weight Lo | 1989 |
Glutamine metabolism in isolated incubated adipocytes of the rat.
Topics: Adipose Tissue; Alanine; Ammonia; Animals; Glucose; Glutamates; Glutamic Acid; Glutaminase; Glutamin | 1988 |
Characterization of stages in development of obesity-diabetes syndrome in sand rat (Psammomys obesus).
Topics: Adipose Tissue; Age Factors; Alanine; Animals; Arvicolinae; Blood Glucose; Carbon Radioisotopes; Dia | 1986 |
Insulin-stimulated glucose disposal is not increased in anorexia nervosa.
Topics: 3-Hydroxybutyric Acid; Adolescent; Adult; Alanine; Anorexia Nervosa; Blood Glucose; Female; Humans; | 1985 |
Glucagon secretion in obesity.
Topics: Adult; Alanine; Child; Diabetes Mellitus; Fasting; Glucagon; Gluconeogenesis; Glucose; Humans; Insul | 1973 |
Hepatic metabolism in normal and genetically obese mice.
Topics: Alanine; Amino Acids; Animals; Blood Glucose; Carbon Radioisotopes; Citrates; Female; Gluconeogenesi | 1974 |
Transport of -aminoisobutyric acid in mammalian pancretic -cells.
Topics: Alanine; Amino Acids; Aminoisobutyric Acids; Animals; Biological Transport; Butyrates; Cyclic AMP; D | 1971 |
Effects of glucose and other modifiers of insulin release on the oxidative metabolism of amino acids in micro-dissected pancreatic islets.
Topics: Alanine; Amino Acids; Animals; Arginine; Carbon Isotopes; Citrates; Cyclic AMP; Depression, Chemical | 1971 |
Glutamate-type hypothalamic-pituitary syndrome in mice treated with aspartate or cysteate in infancy.
Topics: Adipates; Alanine; Amino Acids, Dicarboxylic; Amino Acids, Sulfur; Animals; Animals, Newborn; Aspart | 1974 |
The role of glucagon as a catabolic hormone.
Topics: Alanine; Amino Acids; Ammonia; Carbon Radioisotopes; Fasting; Glucagon; Half-Life; Humans; Obesity; | 1974 |
Weight reduction in obesity by outpatient semistarvation.
Topics: Adult; Alanine; Body Weight; Calcium; Diet, Reducing; Evaluation Studies as Topic; Fasting; Female; | 1974 |
Evaluation of alpha-cell function by infusion of alanine in normal, diabetic and obese subjects.
Topics: Adolescent; Adult; Alanine; Blood Glucose; Diabetes Mellitus; Glucagon; Humans; Injections, Intraven | 1973 |
Changes of free amino acids in pancreatic beta-cells after starvation and substrate deprivation.
Topics: Alanine; Amino Acids; Aminobutyrates; Animals; Aspartic Acid; Carbon Radioisotopes; Chromatography, | 1974 |
Uptake and oxidation of glutamic acid in mammalian pancreatic islets.
Topics: Alanine; Animals; Arginine; Carbon Isotopes; Female; Galactose; Glucose; Glutamates; Glyburide; Hype | 1972 |
Obesity: evidence of decreased secretion of glucagon.
Topics: Adult; Alanine; Animals; Blood Glucose; Fasting; Glucagon; Humans; Injections, Intravenous; Insulin; | 1972 |
Effects of oral alanine administration in fasting obese subjects.
Topics: Administration, Oral; Adult; Alanine; Blood Glucose; Female; Gluconeogenesis; Humans; Hydroxybutyrat | 1973 |
Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man.
Topics: Adult; Alanine; Amino Acids; Blood Glucose; Cushing Syndrome; Dexamethasone; Dietary Proteins; Fasti | 1973 |
[Experimental studies on the problem of insulin resistance in adipositas and diabetes mellitus, with the aid of New Zealand obese mice. Pathogenesis of the obese-hyperglycaemic syndrome (author's transl)].
Topics: Adipose Tissue; Aging; Alanine; Animals; Body Weight; Carbon Radioisotopes; Diabetes Mellitus, Exper | 1973 |
Effect of glucagon on amino acid and nitrogen metabolism in fasting man.
Topics: Acetoacetates; Adult; Alanine; Amino Acids; Ammonia; Blood Glucose; Blood Urea Nitrogen; Fasting; Fa | 1974 |
[Effect of blood sugar decreasing sulfonylureas on the in vitro metabolism of glucose and amino acids in the beta-cells of the pancreas in mice].
Topics: Alanine; Amino Acids; Animals; Arginine; Carbon Isotopes; Depression, Chemical; Female; Glucose; Hyp | 1969 |
Uptake of alanine, arginine and leucine by mammalian pancreatic beta-cells.
Topics: Alanine; Animals; Arginine; Carbon Isotopes; Diazoxide; Fructose; Glucose; Glyburide; Hyperglycemia; | 1971 |
Carbohydrate metabolism of the isolated perfused liver of normal and genetically obese--hyperglycaemic (ob-ob) mice.
Topics: Alanine; Animals; Carbohydrate Metabolism; Carbon Isotopes; Genes, Recessive; Gluconeogenesis; Gluco | 1971 |
Alanine: key role in gluconeogenesis.
Topics: Adult; Alanine; Amino Acids; Body Weight; Forearm; Gluconeogenesis; Humans; Middle Aged; Muscles; Ob | 1970 |
Hormone and amino acid levels in altered nutritional states.
Topics: Adult; Alanine; Amino Acids; Aminobutyrates; Female; Growth Hormone; Humans; Insulin; Isoleucine; Le | 1970 |
Alteration in the urinary excretion rate of amino acids and nitrogen by dietary means in obese and normal human subjects.
Topics: Adult; Alanine; Amino Acids; Creatinine; Female; Humans; Isoleucine; Leucine; Male; Nitrogen; Obesit | 1971 |
Influence of dietary deprivations on plasma concentration of free amino acids of man.
Topics: Adolescent; Adult; Alanine; Amino Acids; Chromatography, Ion Exchange; Diet; Dietary Proteins; Femal | 1968 |